6f3y

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "6f3y" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 6f3y is ON HOLD
+
==Backbone structure of Des-Arg10-Kallidin (DAKD) peptide bound to human Bradykinin 1 Receptor (B1R) determined by DNP-enhanced MAS SSNMR==
-
 
+
<StructureSection load='6f3y' size='340' side='right' caption='[[6f3y]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''>
-
Authors:
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[6f3y]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6F3Y OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6F3Y FirstGlance]. <br>
-
Description:
+
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6f3x|6f3x]], [[6f3w|6f3w]], [[6f3v|6f3v]], [[6f27|6f27]]</td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6f3y FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6f3y OCA], [http://pdbe.org/6f3y PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6f3y RCSB], [http://www.ebi.ac.uk/pdbsum/6f3y PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6f3y ProSAT]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[[http://www.uniprot.org/uniprot/KNG1_HUMAN KNG1_HUMAN]] Congenital high-molecular-weight kininogen deficiency. The disease is caused by mutations affecting the gene represented in this entry.
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/KNG1_HUMAN KNG1_HUMAN]] (1) Kininogens are inhibitors of thiol proteases; (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action); (5) LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting.
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Glaubitz, C]]
 +
[[Category: Joedicke, L]]
 +
[[Category: Kuenze, G]]
 +
[[Category: Mao, J]]
 +
[[Category: Meiler, J]]
 +
[[Category: Michel, H]]
 +
[[Category: Dnp]]
 +
[[Category: Gpcr]]
 +
[[Category: Membrane protein]]

Revision as of 08:34, 10 January 2018

Backbone structure of Des-Arg10-Kallidin (DAKD) peptide bound to human Bradykinin 1 Receptor (B1R) determined by DNP-enhanced MAS SSNMR

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/6f3y"
Personal tools